<html>
<head>PUBMED IDs for OVCA1</head>
<body bgcolor='#C5F0F2'><h1>OVCA1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9782084/'>Cloning and localization of a human diphthamide biosynthesis-like protein-2 gene, DPH2L2.</a> October 23  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10519411/'>Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells.</a> October 16  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11013075/'>Identification and structural analysis of human RBM8A and RBM8B: two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor.</a> October 3  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11062163/'>High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China.</a> November 4  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11123866/'>Genetic factors in ovarian carcinoma.</a> December 21  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11527402/'>Cloning, structure, and expression of the mouse Ovca1 gene.</a> August 31  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11979432/'>OVCA2 is downregulated and degraded during retinoid-induced apoptosis.</a> April 30  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12470655/'>Identification of genes induced by BRCA1 in breast cancer cells.</a> December 10  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14744934/'>Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis.</a> January 28  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/14871925/'>OVCA1: emerging as a bona fide tumor suppressor.</a> February 12  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15485916/'>Identification of the proteins required for biosynthesis of diphthamide, the target of bacterial ADP-ribosylating toxins on translation elongation factor 2.</a> October 16  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15637051/'>Gene trap mutagenesis-based forward genetic approach reveals that the tumor suppressor OVCA1 is a component of the biosynthetic pathway of diphthamide on elongation factor 2.</a> January 8  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15661533/'>OVCA1: tumor suppressor gene.</a> January 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16386221/'>[Chromosome arm 17p13.3: could HIC1 be the one ?].</a> January 3  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16571805/'>White spot syndrome virus open reading frame 222 encodes a viral E3 ligase and mediates degradation of a host tumor suppressor via ubiquitination.</a> March 31  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16759848/'>Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1 -/- epithelial ovarian cancers.</a> June 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18181179/'>Ovca1, a candidate gene of the genetic modifier of Tp53, Mop2, affects mouse embryonic lethality.</a> January 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21487939/'>OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16.</a> October 22  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24895408/'>Role of OVCA1/DPH1 in craniofacial abnormalities of Miller-Dieker syndrome.</a> June 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/28521400/'>OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.</a> May 20  2017<br></body></html>
